3250 MARY ST, COCONUT GROVE, FL
To Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue
Election of Directors and Appointment of RBSM LLP as Auditor
Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%
Regains Compliance with Nasdaq Bid Price Requirement
Announces 1-for-10 Reverse Stock Split to Be Effective Prior to Market Open on April 13, 2026
Financial Results, Press Release
Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
Amended material disclosure
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
Correspondence
Submission Upload
Definitive Revised Proxy Statement